In this prospective, non interventional, observational Post Marketing Survelliance study data are obtained on the efficacy, safety and tolerability of Glucobay treatment on top of sulfonylurea under daily life treatment conditions.Specifically investigated is the influence of Glucobay on Post Prandial Blood Glucose and HbA1c as well as on pateint's weight when added to an already existing sulfonylurea therapy.The study is planned to carried out in 25000 - 30000 patients from 200 trial sites in India.The Post Marketing Survelliance study will be performed with commercially available medication prescribed within regular practice of the physician. No other examination will be performed than would be done without Post Marketing Survelliance study.
Study Type
OBSERVATIONAL
Enrollment
4,564
Oral Glucobay 25 titrated to Glucobay 50 upto three times a day with meals or as per investigators descretion.
Unnamed facility
Many Locations, India
Data collection on body weight
Time frame: 16 weeks
Data collection on blood glucose
Time frame: 16 weeks
Data collection on Hba1c
Time frame: 16 weeks
Data collection on pre treatment concomitant diseases
Time frame: 16 weeks
Safety variables will be summarized using descriptive statistics based on adverse events collection
Time frame: 16 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.